GlassScriptPhysician profile
Emily Ence
NPI 1063784478
$5,894.24
in general payments reported to CMS, 2019-2025
41 companies · $773 in 2025
The $773 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,254 · 2022: $1,361 · 2023: $963 · 2024: $1,544 · 2025: $773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,266 · Entertainment: $13.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,266.26 |
| Entertainment | $13.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,343.38 | 2021-2025 | |
| Viiv Healthcare Company | $730.93 | 2021-2025 | Dovato, Apretude, Cabenuva |
| Lilly USA, LLC | $388.03 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $385.31 | 2021-2024 | |
| Novo Nordisk INC | $373.13 | 2021-2024 | Wegovy, Saxenda, Ozempic |
| Genzyme Corporation | $261.54 | 2024-2025 | |
| Phadia US INC. | $233.20 | 2023-2025 | Immunocap |
| Intuitive Surgical, INC. | $203.39 | 2021 | |
| Hologic Sales and Service, LLC | $187.90 | 2022-2025 | Aptima |
| Glaxosmithkline, LLC. | $176.74 | 2021-2025 | Shingrix, Arexvy, Bexsero |
| Stryker Corporation | $165.27 | 2023 | Clarifix Cryotherapy Device |
| Sanofi Pasteur INC. | $145.96 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $139.28 | 2021-2025 | Breztri, Evusheld, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $138.84 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $124.85 | 2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Ence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.